Newer oral anticoagulants in venous thromboembolism

Newer oral anticoagulants in venous thromboembolism

Venous thromboembolism (VTE) is an important medical condition for morbidity and mortality. Adequate anticoagulant treatment is necessary to reduce short- and long-term VTE related conditions. In the past low molecular weight heparin (LMWH) and Vitamin K antagonists (VKAs) have been the mainstay of...

Full description

Bibliographic Details
Main Authors: Sunil Modi, Ranjan Modi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Journal of Indian College of Cardiology
Subjects:
inr
non-vitamin k antagonist oral anticoagulants
pulmonary embolism
venous thromboembolism
Online Access:http://www.joicc.org/article.asp?issn=1561-8811;year=2021;volume=11;issue=4;spage=172;epage=178;aulast=Modi

Internet

http://www.joicc.org/article.asp?issn=1561-8811;year=2021;volume=11;issue=4;spage=172;epage=178;aulast=Modi

Similar Items